Shingrix Recombinant zoster vaccine is newly added to the market and approved by US FDA and EU EMA. People 50 years of age or older should receive two doses of this vaccine. Shingrix is more than 90% effective at preventing shingles and post-herpetic neuralgia. Side effects are temporary, including sore arm with mild or moderate pain, redness and swelling at injection site, tiredness, muscle pain, a headache, shivering, fever, stomach pain, or nausea. Symptoms went away on their own in about 2 to 3 days. You should not get Shingrix if you have severe allergic rection to any component of the vaccine of the previous dose, currently have shingles or currently are pregnant or breastfeeding.